Table 3.
Associations of reproductive history and exogenous hormone use with endometrial cancer
Cases | Controls | OR1 | 95% CI | OR2 | 95% CI | |
---|---|---|---|---|---|---|
Age at menarche, years | ||||||
<11 | 124 | 342 | 1.00 | Reference | 1.00 | Reference |
11–12 | 308 | 1184 | 0.67 | 0.51, 0.88 | 0.69 | 0.52, 0.92 |
13–14 | 271 | 1142 | 0.62 | 0.47, 0.80 | 0.68 | 0.52, 0.90 |
≥15 | 105 | 451 | 0.59 | 0.43, 0.81 | 0.66 | 0.38, 1.08 |
Missing3 | 3 | 5 | ||||
Ptrend | 0.03 | |||||
Parity | ||||||
Parous | 662 | 2685 | 1.00 | Reference | 1.00 | Reference |
Nulliparous | 143 | 419 | 1.34 | 1.08, 1.66 | 1.38 | 1.11, 1.72 |
Missing3 | 6 | 20 | ||||
Number of births4 | ||||||
1 | 146 | 598 | 1.00 | Reference | 1.00 | Reference |
2 | 154 | 743 | 0.86 | 0.67, 1.11 | 0.82 | 0.63, 1.07 |
3 | 152 | 543 | 1.14 | 0.88, 1.48 | 1.04 | 0.78, 1.37 |
4 | 103 | 343 | 1.23 | 0.92, 1.66 | 1.04 | 0.76, 1.43 |
≥5 | 107 | 458 | 0.93 | 0.69, 1.25 | 0.75 | 0.55, 1.04 |
Ptrend | 0.23 | |||||
Age at first birth, years4 | ||||||
<20 | 273 | 1082 | 1.00 | Reference | 1.00 | Reference |
20–24 | 234 | 875 | 1.08 | 0.89, 1.32 | 1.13 | 0.91, 1.40 |
25–29 | 113 | 418 | 1.08 | 0.84, 1.40 | 1.14 | 0.86, 1.50 |
≥30 | 34 | 283 | 0.48 | 0.33, 1.40 | 0.49 | 0.32, 0.74 |
Missing3 | 8 | 27 | ||||
Ptrend | 0.03 | |||||
Age at last birth, years4 5 | ||||||
<25 | 71 | 260 | 1.00 | Reference | 1.00 | Reference |
25–29 | 109 | 362 | 1.21 | 0.85, 1.71 | 1.34 | 0.91, 1.97 |
30–34 | 83 | 391 | 0.80 | 0.56, 1.15 | 1.12 | 0.73, 1.70 |
≥35 | 59 | 360 | 0.63 | 0.42, 0.92 | 0.87 | 0.55, 1.38 |
Missing3 | 3 | 15 | ||||
Ptrend | 0.40 | |||||
Tubal ligation6 | ||||||
No | 89 | 203 | 1.00 | Reference | 1.00 | Reference |
Yes | 31 | 101 | 0.68 | 0.41, 1.12 | 1.00 | 0.56, 1.77 |
Missing3 | 33 | 123 | ||||
OC duration, years7 | ||||||
Never use | 207 | 685 | 1.00 | Reference | 1.00 | Reference |
<1 | 109 | 408 | 0.88 | 0.60, 1.29 | 0.86 | 0.58, 1.28 |
1–4 | 146 | 530 | 0.87 | 0.61, 1.23 | 0.85 | 0.59, 1.23 |
≥5 | 101 | 679 | 0.42 | 0.26, 0.67 | 0.44 | 0.27, 0.70 |
Missing3 | 139 | 400 | ||||
Ptrend | 0.04 | |||||
Estrogen-only menopausal hormone use8, 9, 10 | ||||||
Never | 484 | 1831 | 1.00 | Reference | 1.00 | Reference |
Ever | 63 | 275 | 0.90 | 0.67, 1.21 | 1.00 | 0.72, 1.39 |
Missing3 | 20 | 146 | ||||
Estrogen-only menopausal hormone duration of use, years8, 9, 10 | ||||||
0 | 484 | 1831 | 1.00 | Reference | 1.00 | Reference |
1–4 | 48 | 252 | 0.76 | 0.55, 1.06 | 0.85 | 0.60, 1.22 |
≥5 | 15 | 31 | 1.77 | 0.93, 3.35 | 2.08 | 1.06, 4.06 |
Missing3 | 20 | 146 | ||||
Ptrend | 0.03 |
OC=oral contraceptives.
Adjusted for age, study, menopausal status,
Adjusted for age, study, menopausal status, body mass index, age at menarche, parity, ever use of oral contraceptives, and smoking status
Number missing within studies included in the analysis
Analysis restricted to parous women
Analysis of participants from studies BWHS, EDGE, FHCRC, WISE studies
Analysis of participants from CCS, EDGE, NYUWHS studies
Analysis of participants from BWHS, CCS, EDGE, FHCRC, MEC, WISE studies
Analysis restricted to postmenopausal women
Analysis of participants from AARP, BWHS, CCS, EDGE, MEC, and WISE studies